TY  - JOUR
AU  - Garcia-Alvarez, Ana
AU  - Pereda, Daniel
AU  - Garcia-Lunar, Ines
AU  - Sanz-Rosa, David
AU  - Fernandez-Jimenez, Rodrigo
AU  - Garcia-Prieto, Jaime
AU  - Nuno-Ayala, Mario
AU  - Sierra, Federico
AU  - Santiago, Evelyn
AU  - Sandoval, Elena
AU  - Campelos, Paula
AU  - Aguero, Jaume
AU  - Pizarro, Gonzalo
AU  - Peinado, Victor I.
AU  - Fernandez-Friera, Leticia
AU  - Garcia-Ruiz, Jose M
AU  - Barberá, Joan Albert
AU  - Castella, Manuel
AU  - Sabaté, Manel
AU  - Fuster, Valentin
AU  - Ibáñez, Borja
PY  - 2016
DO  - 10.1007/s00395-016-0567-0
SN  - 0300-8428
UR  - http://hdl.handle.net/20.500.12105/5215
AB  - Beta-3 adrenergic receptor (beta 3AR) agonists have been shown to produce vasodilation and prevention of ventricular remodeling in different conditions. Given that these biological functions are critical in pulmonary hypertension (PH), we aimed to...
LA  - eng
PB  - Springer
KW  - Beta-3 adrenergic receptor
KW  - Pulmonary hypertension
KW  - Therapy
KW  - Pulmonary vascular resistance
KW  - NITRIC-OXIDE SYNTHASE
KW  - SMOOTH-MUSCLE-CELLS
KW  - BETA(3)-ADRENOCEPTOR AGONIST
KW  - OVERACTIVE BLADDER
KW  - ENDOTHELIAL DYSFUNCTION
KW  - HEART-TRANSPLANTATION
KW  - MAGNETIC-RESONANCE
KW  - ARTERY
KW  - MIRABEGRON
KW  - STIMULATION
TI  - Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension
TY  - journal article
ER  -